<code id='3F2AFD0D07'></code><style id='3F2AFD0D07'></style>
    • <acronym id='3F2AFD0D07'></acronym>
      <center id='3F2AFD0D07'><center id='3F2AFD0D07'><tfoot id='3F2AFD0D07'></tfoot></center><abbr id='3F2AFD0D07'><dir id='3F2AFD0D07'><tfoot id='3F2AFD0D07'></tfoot><noframes id='3F2AFD0D07'>

    • <optgroup id='3F2AFD0D07'><strike id='3F2AFD0D07'><sup id='3F2AFD0D07'></sup></strike><code id='3F2AFD0D07'></code></optgroup>
        1. <b id='3F2AFD0D07'><label id='3F2AFD0D07'><select id='3F2AFD0D07'><dt id='3F2AFD0D07'><span id='3F2AFD0D07'></span></dt></select></label></b><u id='3F2AFD0D07'></u>
          <i id='3F2AFD0D07'><strike id='3F2AFD0D07'><tt id='3F2AFD0D07'><pre id='3F2AFD0D07'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:22183
          WuXi AppTec company logo on a phone screen against a backgroud showing stock graph — coverage from STAT
          Adobe

          WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

          It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

          advertisement

          WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Patients, doctors press FTC to beef up hospital merger scrutiny
          Patients, doctors press FTC to beef up hospital merger scrutiny

          TheFTCandDOJgotafloodofcommentsurgingthemtoadopttheirproposedmergerrules,includingmanyfromregularpeo

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Harvard's David Sinclair gets blowback over aging

          DavidSinclairinhislabatHarvardMedicalSchool.CraigF.Walker/GlobeStaffRenownedHarvardUniversitygenetic